Q04206

PTMD Annotation Information


※ Protein Information

Tag Content
UniProt Accession TF65_HUMAN; Q04206;
Entrez ID 5970
GenBank Protein ID NM_001145138.1; NM_001243984.1; NM_021975.3;
GenBank Nucleotide ID NP_001138610.1; NP_001230913.1; NP_068810.3;
Protein Name Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3)
Gene Name RELA; NFKB3
Organism Homo sapiens
NCBI Taxa ID 9606
Functional DescriptionNF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dim(view all)
Sequence
(Fasta)
MDELFPLIFP AEPAQASGPY VEIIEQPKQR GMRFRYKCEG RSAGSIPGER STDTTKTHPT 60
IKINGYTGPG TVRISLVTKD PPHRPHPHEL VGKDCRDGFY EAELCPDRCI HSFQNLGIQC 120
VKKRDLEQAI SQRIQTNNNP FQVPIEEQRG DYDLNAVRLC FQVTVRDPSG RPLRLPPVLS 180
HPIFDNRAPN TAELKICRVN RNSGSCLGGD EIFLLCDKVQ KEDIEVYFTG PGWEARGSFS 240
QADVHRQVAI VFRTPPYADP SLQAPVRVSM QLRRPSDREL SEPMEFQYLP DTDDRHRIEE 300
KRKRTYETFK SIMKKSPFSG PTDPRPPPRR IAVPSRSSAS VPKPAPQPYP FTSSLSTINY 360
DEFPTMVFPS GQISQASALA PAPPQVLPQA PAPAPAPAMV SALAQAPAPV PVLAPGPPQA 420
VAPPAPKPTQ AGEGTLSEAL LQLQFDDEDL GALLGNSTDP AVFTDLASVD NSEFQQLLNQ 480
GIPVAPHTTE PMLMEYPEAI TRLVTGAQRP PDPAPAPLGA PGLPNGLLSG DEDFSSIADM 540
DFSALLSQIS S 552

※ PTM-Disease Association

NumPTMDiseaseCell TypeTypePTM SitePMID
1PhosphorylationColon cancer/carcinomacell lineP23264896
[Reference]: Rather, its binding to TLR4 inhibits the LPS-induced phosphorylation of p65, production of IL-1 and IL-6, activity of NFB, migration and invasion of SW480 cells
2PhosphorylationBipolar disorderU24075327
[Reference]: Western blot and flow cytometry analyses showed increased phosphorylation levels of p65 NF-B subunit, and MAPKs ERK1/2, and p38 in BD patients in euthymia in comparison with controls
3Serine PhosphorylationColon cancer/carcinomaPS27623784084
[Reference]: TA stabilizes and increases nuclear p65 via p38 mitogen-activated protein kinase- and extracellular signal-regulated kinase-dependent phosphorylation at Ser276 residue
4Serine PhosphorylationHepatocellular carcinoma/Hepatocarcinoma/Hepatomatumor tissueUS53620224721
[Reference]: High expression of p-NF-kBp65 (Ser 536) was found in 88 % (7/8) of FLHCC tissue. In contrast, only 10 % (1/10) of NLT showed high expression for p-NF-kBp65 (Ser 536).?
5Serine PhosphorylationOral squamous cell carcinomaUS53624063540
[Reference]: Moreover, high levels of both phosphorylated p65 (serine 536) and MMP1 in neoplastic cells were positively associated with advanced tumor stages, as well as with regional lymph node metastasis in OSCC

※ Disease Cross-ref Annotation

DatabaseAnnotation
CTD (Curated)
(count: 26)
(view all)
MESH:D019969 ; Amphetamine-Related Disorders
MESH:D001471 ; Barrett Esophagus
MESH:D002545 ; Brain Ischemia
MESH:D001932 ; Brain Neoplasms
MESH:D001943 ; Breast Neoplasms
MESH:D002292 ; Carcinoma, Renal Cell
GWASdb
(count: 1)
rs1049728; Soluble ICAM-1; fatty liver disease|myocardial infarction

※ PTM Sites

PTM Modification Sites
Phosphorylation
(count: 22)
(view all)
131       RDLEQAISQRIQTNN     dbPAF
205       RVNRNSGSCLGGDEI     dbPAF
238       PGWEARGSFSQADVH     dbPAF
254       QVAIVFRTPPYADPS     dbPAF
276       SMQLRRPSDRELSEP     dbPAF
281       RPSDRELSEPMEFQY     dbPAF
Acetylation
(count: 9)
(view all)
122       NLGIQCVKKRDLEQA     PLMD
123       LGIQCVKKRDLEQAI     PLMD
195       APNTAELKICRVNRN     PLMD
218       EIFLLCDKVQKEDIE     PLMD
221       LLCDKVQKEDIEVYF     PLMD
310       KRTYETFKSIMKKSP     PLMD
Ubiquitination
(count: 2)
195       APNTAELKICRVNRN     PLMD
310       KRTYETFKSIMKKSP     PLMD
Malonylation
(count: 2)
122       NLGIQCVKKRDLEQA     PLMD
62        TKTHPTIKINGYTGP     PLMD
Methylation
(count: 6)
218       EIFLLCDKVQKEDIE     PLMD
221       LLCDKVQKEDIEVYF     PLMD
310       KRTYETFKSIMKKSP     PLMD
314       ETFKSIMKKSPFSGP     PLMD
315       TFKSIMKKSPFSGPT     PLMD
37        RGMRFRYKCEGRSAG     PLMD

※ Protein-Protein Interaction

NetworkInteraction
ABSource
C9J8T5Q04206MINT
E9PFC7Q04206HPRD
E9PRY8Q04206IntAct
F5H2U8Q04206HPRD
G3V1N1Q04206HPRD
G3V1S2Q04206MINT
O00221Q04206HPRD; DIP; IntAct
O00255Q04206HPRD; DIP
O14544Q04206IntAct
O14746Q04206HPRD
O14757Q04206HPRD
O14920Q04206HPRD; MINT
O15111Q04206HPRD; DIP; IntAct; MINT;IntAct
O15273Q04206IntAct
O15294Q04206MINT
O15379Q04206HPRD; MINT
O15524Q04206HPRD; MINT
O43318Q04206HPRD
O43823Q04206HPRD
O75582Q04206HPRD; IntAct; MINT
O75925Q04206HPRD
O94992Q04206HPRD
O94993Q04206MINT
O95571Q04206HPRD
O95816Q04206IntAct; MINT
O95863Q04206IntAct
O96019Q04206HPRD
P01100Q04206HPRD
P01106Q04206HPRD
P02458Q04206IntAct
P02746Q04206IntAct
P03372Q04206HPRD; IntAct
P04083Q04206IntAct
P04150Q04206HPRD
P05186Q04206MINT
P05412Q04206HPRD
P06401Q04206HPRD
P06748Q04206IntAct
P07998Q04206IntAct
P08047Q04206HPRD; IntAct
P08621Q04206IntAct
P09429Q04206HPRD
P09874Q04206HPRD;IntAct; MINT
P0CG48Q04206MINT
P10275Q04206HPRD
P10914Q04206HPRD
P11831Q04206HPRD
P12004Q04206IntAct; MINT
P13501Q04206IntAct
P14316Q04206HPRD
P14598Q04206MINT
P14618Q04206IntAct
P14859Q04206HPRD
P16403Q04206IntAct; MINT
P17612Q04206HPRD; MINT
P17676Q04206HPRD
P18146Q04206HPRD
P18847Q04206IntAct
P19793Q04206HPRD
P19838Q04206DIP; IntAct; MINT;IntAct;HPRD
P20226Q04206HPRD
P20711Q04206IntAct
P21673Q04206IntAct
P21675Q04206HPRD
P21980Q04206HPRD; IntAct
P23396Q04206HPRD; IntAct;IntAct; MINT
P24158Q04206HPRD
P25791Q04206IntAct
P25963Q04206HPRD; DIP; IntAct; MINT;IntAct
P26373Q04206MINT
P29590Q04206HPRD
P30153Q04206MINT
P30154Q04206HPRD
P34932Q04206DIP
P35251Q04206HPRD
P35637Q04206HPRD
P35869Q04206HPRD
P40763Q04206HPRD; IntAct
P41279Q04206HPRD; DIP
P42224Q04206HPRD
P42226Q04206HPRD
P43699Q04206HPRD
P46531Q04206HPRD
P47712Q04206DIP
P49716Q04206HPRD
P49841Q04206IntAct
P49848Q04206HPRD
P50750Q04206HPRD
P52292Q04206HPRD; IntAct
P52564Q04206HPRD
P53779Q04206IntAct
P56597Q04206MINT
P58546Q04206HPRD
P60510Q04206HPRD
P61371Q04206IntAct
P62158Q04206HPRD;IntAct; MINT
P62829Q04206IntAct
P62991Q04206MINT
P67775Q04206HPRD; MINT
P68400Q04206HPRD; MINT
P84022Q04206IntAct
Q00403Q04206HPRD; MINT
Q00653Q04206HPRD; DIP; MINT
Q00796Q04206IntAct
Q00987Q04206IntAct
Q01201Q04206HPRD; DIP
Q04206Q04206HPRD; IntAct
Q04206Q04864HPRD; DIP; IntAct
Q04206Q04912HPRD
Q04206Q05513HPRD; MINT
Q04206Q06187HPRD
Q04206Q07869HPRD
Q04206Q08117HPRD
Q04206Q08211HPRD; IntAct
Q04206Q09472HPRD; IntAct; MINT
Q04206Q12888HPRD
Q04206Q13485IntAct
Q04206Q13526HPRD
Q04206Q13547HPRD; IntAct; MINT
Q04206Q13576DIP
Q04206Q13625IntAct; MINT;HPRD
Q04206Q14145IntAct
Q04206Q14653HPRD
Q04206Q14690HPRD; IntAct
Q04206Q15544HPRD
Q04206Q15650HPRD; IntAct
Q04206Q15653HPRD; DIP; IntAct; MINT
Q04206Q15672HPRD
Q04206Q15853IntAct
Q04206Q16539MINT
Q04206Q16566HPRD
Q04206Q4LE28HPRD
Q04206Q5VVH5HPRD
Q04206Q7Z4G1IntAct
Q04206Q86UE4IntAct
Q04206Q86VX2IntAct
Q04206Q86X55HPRD
Q04206Q86X83IntAct
Q04206Q8IV45HPRD
Q04206Q8N1L9IntAct
Q04206Q8N668HPRD; IntAct; MINT
Q04206Q8N6T7IntAct
Q04206Q8NE01IntAct
Q04206Q8NFH8HPRD
Q04206Q8NFZ5HPRD; DIP
Q04206Q8TAD8HPRD
Q04206Q8TBK2IntAct
Q04206Q8WTS6DIP; MINT
Q04206Q8WUF5HPRD
Q04206Q92499HPRD
Q04206Q92750HPRD
Q04206Q92769HPRD
Q04206Q92793IntAct
Q04206Q92831HPRD; MINT
Q04206Q96BH1HPRD
Q04206Q96EB6HPRD; IntAct
Q04206Q96JB5IntAct
Q04206Q96L73DIP
Q04206Q96RI1IntAct
Q04206Q96RU7HPRD
Q04206Q96ST3HPRD
Q04206Q99576HPRD
Q04206Q99684IntAct
Q04206Q99767HPRD
Q04206Q9BVS4IntAct
Q04206Q9GZQ3IntAct
Q04206Q9H0A8IntAct
Q04206Q9H9B1IntAct
Q04206Q9HD26IntAct
Q04206Q9NX08IntAct
Q04206Q9NY61HPRD; IntAct
Q04206Q9NYL4IntAct
Q04206Q9UBK9IntAct
Q04206Q9UHD2HPRD
Q04206Q9UL18IntAct
Q04206Q9ULX6DIP
Q04206Q9UNL4HPRD
Q04206Q9UNN5HPRD
Q04206Q9Y230IntAct; MINT
Q04206Q9Y297HPRD
Q04206Q9Y2K7DIP
Q04206Q9Y618HPRD
Q04206Q9Y6G5IntAct
Q04206Q9Y6Q9HPRD; MINT
Q04206Q9Y6X2HPRD